Latest / The OBservations Podcast
Groundbreaking Research that Shows Flawed REMS Around Mifepristone, Part 2
The FDA says the evidence supported removing the in-person dispensing requirement for mifepristone. Dr. Ingrid Skop explains how the studies behind that decision show the opposite.
In part 2 of this conversation, Dr. Christina Francis continues her discussion with Dr. Ingrid Skop about a paper she co-authored that critically reviews the studies the FDA cited when it dropped the requirement. The findings raise serious concerns.
Learn:
Why follow-up gaps matter, with some studies losing 30, 50, even 70 percent of women, and why she says complication reporting is incomplete.
The issues with the…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.